UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029415
Receipt number R000033044
Scientific Title Open-Label Study for reduction of brain amyloid beta (Abeta) by removal of blood Abeta in Alzheimer's Disease
Date of disclosure of the study information 2017/11/01
Last modified on 2021/04/07 12:20:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open-Label Study for reduction of brain amyloid beta (Abeta) by removal of blood Abeta in Alzheimer's Disease

Acronym

Open-Label Study for brain Abeta reduction by blood Abeta removal

Scientific Title

Open-Label Study for reduction of brain amyloid beta (Abeta) by removal of blood Abeta in Alzheimer's Disease

Scientific Title:Acronym

Open-Label Study for brain Abeta reduction by blood Abeta removal

Region

Japan


Condition

Condition

Alzheimer's Disease, Mild Cognitive Impairment

Classification by specialty

Nephrology Neurology Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of blood Abeta removal on brain Abeta in mild Alzheimer's disease and MCI patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of brain A beta measured by PIB/PET
from the starting point to the end of sequential treatments of blood A beta removal

Key secondary outcomes

Change of cognitive functions measured by MMSE,WMS-R, GDS, and ADAS-JCog, from the starting point to the end of sequential treatments of blood Abeta removal


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Removal of blood Abeta by apheresis
1) Devices for Abeta removal from the blood;
1-1) hexadecyl alkylated cellulose beads (HDC),
1-2) dialyzers made of polysulfone (PSf) or polyethersulfone (PES)
2) blood purification period; 1-3 hr
3) Protocol
3-1) Protocol A; 1 session/week x 24w. One or two series.
3-2) Protocol B; 1 session/week x 12w + 1/month x 9M

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Non diabetic MCI/mild AD patients whose Abeta deposition in the brain is confirmed by PIB/PET

Key exclusion criteria

1) diabetic patients
2) abnormal numbers of platelets or erythrocytes
3) with complications of severe circulatory or cardiac disorders
4) past medical history of cerebrovascular disease (infarction, bleeding etc.)
5) others whom the principal investigator decides to exclude

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Yukio
Middle name
Last name Yuzawa

Organization

Fujita Health University

Division name

Department of Nephrology, School of Medicine

Zip code

470-1192

Address

1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan,

TEL

0562-93-2353

Email

yukio-y@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Kazunori
Middle name
Last name 1. Kazunori Kawaguchi 2. Midori Hasegawa

Organization

Fujita Health University

Division name

1,3. Faculty of Clinical Engineering, School of Health Sciences, 2. Department of Nephrology, School

Zip code

470-1192

Address

1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan,

TEL

0562-93-2619

Homepage URL


Email

kkawagu@fujita-hu.ac.jp


Sponsor or person

Institute

Department of Nephrology, School of Medicine, Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Fujita Health University

Address

1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan,

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 10 Month 03 Day

Date of IRB

2017 Year 08 Month 16 Day

Anticipated trial start date

2017 Year 11 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry

2025 Year 03 Month 31 Day

Date trial data considered complete

2025 Year 03 Month 31 Day

Date analysis concluded

2026 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 10 Month 04 Day

Last modified on

2021 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033044


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name